1. Home
  2. RSF vs BTMD Comparison

RSF vs BTMD Comparison

Compare RSF & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RiverNorth Capital and Income Fund

RSF

RiverNorth Capital and Income Fund

HOLD

Current Price

$14.53

Market Cap

59.1M

Sector

Finance

ML Signal

HOLD

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$2.53

Market Cap

65.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSF
BTMD
Founded
2016
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.1M
65.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RSF
BTMD
Price
$14.53
$2.53
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$2.83
AVG Volume (30 Days)
10.7K
410.5K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
10.61%
N/A
EPS Growth
N/A
722.22
EPS
N/A
0.06
Revenue
N/A
$192,219,000.00
Revenue This Year
N/A
$2.03
Revenue Next Year
N/A
$6.58
P/E Ratio
N/A
$41.00
Revenue Growth
N/A
N/A
52 Week Low
$14.23
$1.27
52 Week High
$15.07
$4.75

Technical Indicators

Market Signals
Indicator
RSF
BTMD
Relative Strength Index (RSI) 42.58 62.95
Support Level $14.52 $2.37
Resistance Level $14.72 $2.79
Average True Range (ATR) 0.08 0.17
MACD -0.01 0.04
Stochastic Oscillator 15.00 94.38

Price Performance

Historical Comparison
RSF
BTMD

About RSF RiverNorth Capital and Income Fund

RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Share on Social Networks: